Clinical Trial Update: A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and pharmacokinetics of repeated-dose micafungin as antifungal prophylaxis in children and adolescents undergoing hematopo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Fungal Infections | Phase 1 | Status: COMPLETED